by 
Shigella is a highly contagious bacterial infection that causes bloody diarrhea and is typically spread through contaminated food or water. With increasing globalization and international travel, shigella infections have been on the rise worldwide. Shigella test kits help in the prompt diagnosis and treatment of the infection, thereby curbing its spread. These kits detect the presence of Shigella bacteria in stool or rectal swab samples through rapid antibody-based or molecular assays.
The global Shigella Test Kit market is estimated to be valued at US$ 106.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The development of rapid point-of-care test kits for shigella is a key trend witnessed in the market. Traditional culture-based tests require 2-7 days to confirm the presence of Shigella bacteria. On the other hand, rapid antigen-based lateral flow assays and PCR-based molecular assays provide results within 10-30 minutes directly from stool or rectal swab samples. Their ease of use and quick turnaround time facilitate prompt treatment decisions, particularly useful in outbreak situations. Manufacturers are focusing on research to develop reliable and low-cost rapid diagnostic kits for resource-limited settings where the infection is more prevalent.
Porter’s Analysis
Threat of new entrants: Low barrier to entry but significant capital needed for R&D and brand awareness. Large competitors dominate the market.
Bargaining power of buyers: Buyers have moderate bargaining power due to alternative product availability from competitors.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to availability of substitute raw materials.
Threat of new substitutes: Threat of substitutes is low as test kits have specificity for detecting Shigella infection.
Competitive rivalry: Market dominated by few global players. Intense competition on pricing and quality.
Key Takeaways
The global Shigella Test Kit market is expected to witness high growth over the forecast period.
Regional analysis: North America is expected to have the largest market share during the forecast period. High prevalence of shigellosis cases coupled with advanced healthcare infrastructure drives market growth in this region. Europe is also expected to account for a considerable market share owing to increasing R&D initiatives for infectious disease diagnostics.
Key players: Key players operating in the Shigella Test Kit market are Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., and CTK Biotech Inc. Thermo Fisher Scientific Inc. holds the major market share due to its diverse product portfolio.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
